alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 32.1
                                                                    ------------

                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. SS. 1350)

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. ss. 1350),
the undersigned, Corey M. Horowitz, Chief Executive Officer and Chairman of
Network-1 Security Solutions, Inc., a Delaware corporation (the "Company"), does
hereby certify to his knowledge, that:

The Quarterly Report of Form 10-QSB for the quarter ended March 31, 2007 of the
Company (the "Report") fully complies with the requirements of Section 13(a) or
15(d) of the Securities Act of 1934, and the information contained in the Report
fairly presents, in all material respects, the financial condition and results
of operations of the Company.



/S/ COREY M. HOROWITZ
------------------------------------
CHIEF EXECUTIVE OFFICER AND CHAIRMAN
MAY 11, 2007
Exhibit 31.1
**CERTIFICATION**
I, Randall W. White, President and CEO of Educational Development Corporationcertify that:
1. I have reviewed this annual report on Form 10-K of EducationalDevelopment Corporation. 2. Based on my knowledge, this annual report does not contain any untruestatement of a material fact or omit to state a material fact necessary tomake the statements made, in light of the circumstances under which suchstatements were made, not misleading with respect to the period covered bythis annual report; 3. Based on my knowledge, the financial statements, and other financialinformation included in this annual report, fairly present in all materialrespects the financial condition, results of operations and cash flows ofthe registrant as of, and for, the periods presented in this annualreport; 4. The registrant’s other certifying officers and I are responsible forestablishing and maintaining disclosure controls and procedures (asdefined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and wehave: a) designed such disclosure controls and procedures to ensure that materialinformation relating to the registrant, including its consolidatedsubsidiaries, is made known to us by others within those entities,particularly during the period in which this annual report is beingprepared; b) evaluated the effectiveness of the registrant’s disclosure controls andprocedures as of a date within 90 days prior to the filing date of thisannual report (the “Evaluation Date”); and c) presented in this annual report our conclusions about the effectivenessof the disclosure controls and procedures based on our evaluation as ofthe Evaluation Date; 5. The registrant’s other certifying officers and I have disclosed, based onour most recent evaluation, to the registrant’s auditors and the auditcommittee of registrant’s board of directors (or persons performing theequivalent function): a) all significant deficiencies in the design or operation of internalcontrols which could adversely affect the registrant’s ability to record,process, summarize and report financial data and have identified for theregistrant’s auditors any material weaknesses in internal controls; and b) any fraud, whether or not material, that involves management or otheremployees who have a significant role in the registrant’s internalcontrols; and 6. The registrant’s other certifying officers and I have indicated in thisannual report whether or not there were significant changes in internalcontrols or in other factors that could significantly affect internalcontrols subsequent to the date of our most recent evaluation, includingany corrective actions with regard to significant deficiencies andmaterial weaknesses.         Date: May 25, 2004      By      /s/ Randall W. White   Randall W. White   President and Chief Executive Officer
Exhibit
31.1





CERTIFICATIONS





I,
Gregory Frost, certify that:





1. I have
reviewed this quarterly report on Form 10-Q of Able Energy Inc.;





2. Based
on my knowledge, this report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading
with respect to the period covered by this report;





3. Based
on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the registrant as of, and
for, the periods presented in this report;





4. The
registrant's other certifying officer and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) for the registrant and have:





a)
Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;





b)
Evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and





c)
Disclosed in this report any change in the registrant's internal control over
financial reporting that occurred during the registrant's most recent fiscal
quarter (the registrant's fourth fiscal quarter in the case of an annual report)
that has materially affected, or is reasonably likely to materially affect, the
registrant's internal control over financial reporting; and





5. The
registrant's other certifying officer and I have disclosed, based on our most
recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent functions):





a) All
significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to
adversely affect the registrant's ability to record, process, summarize and
report financial information; and





b) Any
fraud, whether or not material, that involves management or other employees who
have a significant role in the registrant's internal control over financial
reporting.





November
13, 2008





/s/Gregory
      Frost
              Gregory
      Frost
              Chief
      Executive Officer
No. 10-5791.

#### Vasila Georgieva, Petitioner v. Barnes & Noble.

562 U.S. 1088, 131 S. Ct. 697,

2010 U.S. LEXIS 9087.

178 L. Ed. 2d 527,

November 29, 2010.

Petition for rehearing denied.

Former decision, 562 U.S. 967, 131 S. Ct. 499, 178 L. Ed. 2d 297, 2010 U.S. LEXIS 8065.
No. 10-328.

#### El-Shifa Pharmaceutical Industries Company, et al., Petitioners v. United States.

562 U.S. 1178, 131 S. Ct. 997,

178 L. Ed. 2d 826,

2011 U.S. LEXIS 829.

January 18, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the District of Columbia Circuit denied.

Same case below, 391 U.S. App. D.C. 51, 607 F.3d 836.
# C_2014045EN.01004504.xml

| 15.2.2014 | EN | Official Journal of the European Union | C 45/45 |
| --- | --- | --- | --- |

15.2.2014

EN

Official Journal of the European Union

C 45/45

---

Order of the General Court of 25 November 2013 — Euromed v OHIM — DC Druck-Chemie (EUROSIL)

(Case T-524/13) (1)

1

2014/C 45/84

Language of the case: English

The President of the Fifth Chamber has ordered that the case be removed from the register.

---

(1)  OJ C 352, 30.11.2013.

1

---
# Pcc^ ^ %^ii-6ih 5

!:v:cri i
n 0 n 0 ' December 6 , 201 1

Mr
. Denni s DeVan

y Offic e o f Aviatio n Analysi s U
. S
. Departmen t

o f Transportatio n 40 0 Sevent

h Stree t S W Washington , D

C 2059 0 Dea r Mr
. DeVany , It ha s jus t come t o ou r

attentio n tha t

th e Departmen t

o f Transportatio n ha s awarde d th e Brainerd , M

N airpor t contrac t t o Grea t Lake s Airlines
. A

s Mayor s o

f communitie s directl y impacte dby thi s decision , w e wis h t o expres s ou r dee p concern . First : Grea

t Lake s Airline s di dnot , an dcontinue s t o not , mee t th e minimu mbiddin g requirements
. Second : th e loadfacto r

fo r Brainer di s quit e high
. Servic e wil l b e considerabl y diminishe dthroug h th e us e o f smalle r plane s that , in addition , d o no t offe r accessibility fo

r thos e needin g assistanc e withou t impactin g th e remainin g passengers . Fewer

seat s als o impact s busines s developmen t i n th e area . Third : w e hav e ye t

t o b e assure dtha t

ther e will b e flow-throug h with Deltas o tha t luggag e will automaticall y b e transferre dfo r fligh t continuations
. Finally , i t i s ou r opinio n tha t

th e Departmen t

o f Transportation s shoul densur e tha t ai r trave l fro mth e Brainer dAirport

shoul dimprov e with ane w carrie r - i t shoul d no t b e aste p backward...whic h thi s decisio n definitel y is
. Sincerely ,

Joann Weaver , Mayo

r Breez y Point , M

N Darrel l Schneider , Mayo r Crosslake , M

N •Jo

n Lubke , Mayo

r Jenkins , M

N

Bria n Lehman , Mayo

r Nisswa , M

N Nancy Adams , Mayo r Pequo t Lakes , M N Ji

mSabas , Mayo

r Pin e River , M

N
The 12-Dose Regimen for 

Latent Tuberculosis (TB) Infection 

Information for Clinicians

Treatment of latent TB infection reduces 

the risk that latent TB infection will progress 

to TB disease.

•Up to 13 million people in the United States have latent TB infection. Without treatment, 

they are at risk for developing TB disease. 

•Eliminating TB in the United States requires expanding testing and treatment of 

latent TB infection. 

• More than 80 percent of TB cases in the United States are attributed to longstanding, 

untreated latent TB infections.

New updated CDC recommendations expand 

options for patients and clinicians.

•CDC’s updated recommendations for use of 12-week once-weekly isoniazid and 

rifapentine (3HP), previously recommended for most persons aged 12 years and 

older, have been expanded to include: 

•Children ages 2 - 11

•People living with HIV taking antiretroviral treatment 

(with acceptable drug-drug interactions with rifapentine)

•Clinicians can now prescribe the 12-dose regimen to patients as self-administered 

therapy, meaning patients can take medicines themselves.

•Previously, the 12-dose treatment regimen had to be administered by directly observed 

therapy, meaning a health worker had to observe each dose. 

CS292653E

www.cdc.gov/tb
The 12-Dose Regimen for 

Latent Tuberculosis (TB) Infection

Information for Clinicians

The 12-dose regimen is convenient and 

has higher rates of treatment completion. 

•The 12-dose regimen is the shortest of several available regimens recommended 

for treating latent TB infection. 

•Clinicians should choose the mode of administration (directly observed therapy or 

self-administered therapy) based on local practice, individual patient attributes and 

preferences, and other considerations including risk of progression to severe forms 

of TB disease.

Clinicians should educate patients about possible 

adverse events, and instruct patients to use a 

symptom checklist and medication intake log.

•Clinicians should follow guidance on early detection and management of adverse events.

•Patients on the 12-dose treatment regimen should be evaluated monthly to assess 

adherence and treatment-associated adverse events.

Resources:

• Update on Recommendations for Use of Once-weekly Isoniazid-Rifapentine Regimen

to Treat Latent Mycobacterium tuberculosis Infection

• 12-Dose Treatment Regimen for Latent TB Infection Clinician 

Frequently Asked Questions (FAQs)

• 12-Dose Treatment Regimen for Latent TB Infection Pharmacist 

Frequently Asked Questions (FAQs)

• Latent TB Infection Online Resource Hub

• Patient Education Materials for the 12-Dose Treatment Regimen for Latent TB Infection 

• State and Local TB Control Offices

• TB Centers of Excellence for Training, Education, and Medical Consultation

www.cdc.gov/tb
Exhibit
31.2





CERTIFICATIONS





I, Daniel
L. Johnston certify that:





1. I have
reviewed this Quarterly Report on Form 10-Q of Able Energy, Inc.;





2. Based
on my knowledge, this Report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading
with respect to the period covered by this Report;





3. Based
on my knowledge, the financial statements, and other financial information
included in this Report, fairly present in all material respects the financial
condition, results of operations and cash flows of the registrant as of, and
for, the periods presented in this Report;





4. The
registrant's other certifying officer and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) for the registrant and have:





a)
Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this Report is being prepared;





b)
Evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this Report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this Report based on such evaluation; and





c)
Disclosed in this Report any change in the registrant's internal control over
financial reporting that occurred during the registrant's most recent fiscal
quarter (the registrant's fourth fiscal quarter in the case of an Annual Report)
that has materially affected, or is reasonably likely to materially affect, the
registrant's internal control over financial reporting; and





5. The
registrant's other certifying officer and I have disclosed, based on our most
recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent functions):





a) All
significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to
adversely affect the registrant's ability to record, process, summarize and
report financial information; and





b) Any
fraud, whether or not material, that involves management or other employees who
have a significant role in the registrant's internal control over financial
reporting.





April 2,
2008





/s/Daniel
      L. JohnstonDaniel
      L. JohnstonChief
      Financial Officer
No. 10-5389.

#### Scott Jay MacKenzie, Petitioner v. Rick Thaler, Director, Texas Department of Criminal Justice, Correctional Institutions Division.

562 U.S. 1088, 131 S. Ct. 696,

2010 U.S. LEXIS 9309.

178 L. Ed. 2d 525,

November 29, 2010.

Petition for rehearing denied.

Former decision, 562 U.S. 919, 131 S. Ct. 289, 178 L. Ed. 2d 189, 2010 U.S. LEXIS 7428.
# Police Week Spotlight: Officer Randall Guratosky

/ Published May 10, 2016
RICHMOND, Va., 
As part of National Police Week observances, Defense Logistics Agency Aviation and DLA Installation Support at Richmond will spotlight police officers at Defense Supply Center, Richmond, Virginia, who selflessly secure and protect the base, its people and its neighbors.

In addition, a special ceremony to honor and pay respect to current officers and officers who gave the ultimate sacrifice in the performance of their duty will be held May 12.

National Police Week ’16 will be celebrated across the country May 15 - 21.  

According to policeweek.org, in 1962, President John F. Kennedy proclaimed and designated May 15 as Peace Officers' Memorial Day and the week in which that date falls as Police Week.  Events have been celebrated since that time to honor police officers who have paid the ultimate sacrifice to serve and protect our nation’s communities.

**Name:  Officer Randall Guratosky**

**How long have you been in law enforcement?**

I am new to law enforcement but have been familiar with some procedures and the mindset of a law enforcement officer because I worked with them when I served in the Marines. I have been at DSCR for approximately four months.

**What made you decide to go into law enforcement and public service?**

I wanted to go into law enforcement for quite some time. I have a passion for helping and protecting people who are not able to provide those things for themselves. 

**What is your most memorable event from your job as a police officer?**

My most memorable event from my job as a police officer would have to be when I got the call and was offered a police officer position here at DSCR.  I was ecstatic to go into the field I have a strong passion for. 

**What is your greatest achievement on the job?**

My greatest achievement is participating in the color guard at ceremonies. Being part of a color guard is something we don’t get to do often, but it is such a great honor to showcase our police officers and parade our country’s flag. 

**What’s the most rewarding thing about being a police officer?**

To me, the most rewarding thing about being a police officer is serving the public in a positive way, as well as the strong bond among my fellow LEOs.

**Have you had any mentors in your career?  If so, how have/did they help?**

I consider any officers who have an extended period of time in this career to be somewhat of a mentor. They have a lot to offer to help newer officers learn and grow in our careers. 

**How do you define excellence?**

I define excellence as doing your job accurately, safely and with dignity and respect, and when needed, going above and beyond what is asked of you.

**What makes for a great day on the job?**

A great day on the job means the base and our people are secure and safe, and everyone gets to go home.  

**What would you say to someone to encourage them to go into public service?**

If you’re thinking about going into public service, I suggest speaking with an experienced person in the field and researching what the job entails. Also, always stay positive.
[Federal Register Volume 63, Number 127 (Thursday, July 2, 1998)]
[Notices]
[Page 36276]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-17610]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[Docket No. 72-9]


Notice of Issuance of Amendment to Materials License SNM-2504, 
Public Service Company of Colorado, Fort St. Vrain Independent Spent 
Fuel Storage Installation

    The U.S. Nuclear Regulatory Commission (the Commission) has issued 
Amendment 5 to Materials License No. SNM-2504 held by the Public 
Service Company of Colorado (PSCo) for the receipt, possession, 
storage, and transfer of spent fuel at the Fort St. Vrain (FSV) 
independent spent fuel storage installation (ISFSI), located in Weld 
County, Colorado. The amendment is effective as of the date of 
issuance.
    By application dated November 25, 1997, PSCo requested an amendment 
to revise Materials License SNM-2504 and the Technical Specifications 
for the FSV ISFSI to (1) replace 10 CFR 50 Program references with 
stand-alone ISFSI program references due to the termination of the FSV 
10 CFR part 50 license, (2) delete references to previously authorized 
material that is not stored at the ISFSI, and (3) revise the Technical 
Specifications to accurately reflect the current ISFSI activities.
    This amendment complies with the standards and requirements of the 
Atomic Energy Act of 1954, as amended (the Act), and the Commission's 
rules and regulations. The Commission has made appropriate findings as 
required by the Act and the Commission's rules and regulations in 10 
CFR Chapter I, which are set forth in the license amendment.
    In accordance with 10 CFR 72.46(b)(2), a determination has been 
made that the amendment does not present a genuine issue as to whether 
public health and safety will be significantly affected. Therefore, the 
publication of a notice of proposed action and an opportunity for 
hearing or a notice of hearing is not warranted. Notice is hereby given 
of the right of interested persons to request a hearing by July 31, 
1998, on whether the action should be rescinded or modified.
    The Commission has determined that the issuance of the amendment 
will not result in any significant environmental impact and that, 
pursuant to 10 CFR 51.22(c)(10)(ii), an environmental assessment need 
not be prepared in connection with issuance of the amendment.
    Documents related to this action are available for public 
inspection at the Commission's Public Document Room located at the 
Gelman Building, 2120 L Street, NW, Washington, DC 20555.

    Dated at Rockville, Maryland, this 24th day of June 1998.

    For the Nuclear Regulatory Commission.

William F. Kane,
Director, Spent Fuel Project Office, Office of Nuclear Material Safety 
and Safeguards.
[FR Doc. 98-17610 Filed 7-1-98; 8:45 am]
BILLING CODE 7590-01-P
www.cdc.gov/transportationsafety

Transportation Safety 

CDC’s Injury Center Uses Data and Research to Save Lives

Our Mission

To provide public health 

leadership to reduce 

motor vehicle crash 

deaths and injuries

Crash deaths cost over 

$430 billion 

annually

More than 

7,000 pedestrians 

were killed in crashes involving a motor 

vehicle—that’s about one death 

every 75 minutes

An additional 2.1 million

people were treated in emergency 

departments for crash-related injuries 

 CDC conducts critical surveillance, research, and evaluation

to provide evidence-based recommendations. CDC supports a 

Safe System approach that works to keep everyone safe on the 

road through systems to reduce human error and protect people 

from injury and deaths when they make mistakes

 Motor vehicle crashes are a leading cause of death in the United 

States among people ages 1–75 and the leading cause of death for 

children, youth, and young adults ages 5–24 

CDC supports states, tribes, and 

communities to reduce motor vehicle 

crash deaths and injuries

Providing the MyMobility Plan, which guides older adults 

on building a plan to stay independent as they age by 

staying safe at home and mobile in their community 

Funding tribes to increase their capacity to adapt, 

implement, and evaluate programs to reduce crash injuries 

and share resources such as the Best Practices Guide

Creating actionable resources to assess, plan, and implement 

improved laws and practices that reduce crash deaths among 

children (such as the Booster Seat Planning Guide), and to 

reduce teen crashes (such as the Graduated Driver Licensing

System Planning Guide and Parents Are the Key)

Publishing state-specific information about the cost of crash 

deaths, alcohol-impaired driving, and the use of seat belts, car 

seats, and booster seats 

Sharing promising strategies to prevent drug-impaired driving

and distracted driving

Providing the Linking Information for Nonfatal Crash

Surveillance (LINCS guide) to improve understanding of motor 

vehicle crash injuries and the resulting health outcomes 

and costs through data linkage

In the United States in 2020

Almost 41,000

people died in crashes—that’s 

more than 110 people every day 

adults ages 65 and 

older died in crashes 7,500

children ages 12 and 

younger died in motor 

vehicle crashes

600

of these children 

were not buckled up

in a car seat, booster 

seat, or seat belt

1 in 3

of all crash deaths 

involved an alcoholimpaired driver 

1/3

Approximately

SEPTEMBER 2022